{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T18:32:07Z","timestamp":1787250727985,"version":"build-2736575974"},"reference-count":25,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>This paper reports on a validated, stability-indicating high-performance thin-layer chromatography (HPTLC)-based assay for the quantification of nitrofurazone in an ointment formulation. The simple and rapid HPTLC analysis was performed on silica gel 60 F254 HPTLC plates using toluene\u2013acetonitrile\u2013ethyl acetate\u2013glacial acetic acid (6:2:2:0.1, v\/v) as the mobile phase and chloroform\u2013acetone (9:1, v\/v) as the solvent. The method was validated in accordance with the guidelines set by both the International Council for Harmonisation (ICH) and the United States Food and Drug Administration (FDA). Nitrofurazone appeared as a sharp band with a RF value of 0.18. The method showed excellent linear regression between the concentration ranges of 30\u2013180 ng\/band (R = 99.99%). The limit of detection was found to be 10.39 ng\/band, and the limit of quantification was 31.49 ng\/band. The forced degradation of nitrofurazone via photolysis, oxidation, acid and alkaline hydrolyses confirmed the assay\u2019s suitability for stability studies involving nitrofurazone. Therefore, the method is considered suitable for the routine quality control of nitrofurazone ointment.<\/jats:p>","DOI":"10.3390\/molecules30163429","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T13:18:14Z","timestamp":1755695894000},"page":"3429","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Development and Validation of a Stability-Indicating HPTLC-Based Assay for the Quantification of Nitrofurazone Ointment"],"prefix":"10.3390","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4958-2745","authenticated-orcid":false,"given":"K. M. Yasif Kayes","family":"Sikdar","sequence":"first","affiliation":[{"name":"Department of Pharmacy and Centre for Optimisation of Medicines, School of Health and Clinical Sciences, University of Western Australia, Crawley, WA 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley","family":"Andrews","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Centre for Optimisation of Medicines, School of Health and Clinical Sciences, University of Western Australia, Crawley, WA 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Pacecca","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Centre for Optimisation of Medicines, School of Health and Clinical Sciences, University of Western Australia, Crawley, WA 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliyah","family":"Petker","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Centre for Optimisation of Medicines, School of Health and Clinical Sciences, University of Western Australia, Crawley, WA 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Samie","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Centre for Optimisation of Medicines, School of Health and Clinical Sciences, University of Western Australia, Crawley, WA 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0154-4179","authenticated-orcid":false,"given":"Tomislav","family":"Sostaric","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Centre for Optimisation of Medicines, School of Health and Clinical Sciences, University of Western Australia, Crawley, WA 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7307-0742","authenticated-orcid":false,"given":"Lee Yong","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Centre for Optimisation of Medicines, School of Health and Clinical Sciences, University of Western Australia, Crawley, WA 6009, Australia"},{"name":"Institute for Paediatric Perioperative Excellence, University of Western Australia, Perth, WA 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9333-6536","authenticated-orcid":false,"given":"Md Khairul","family":"Islam","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Centre for Optimisation of Medicines, School of Health and Clinical Sciences, University of Western Australia, Crawley, WA 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8773-3036","authenticated-orcid":false,"given":"Cornelia","family":"Locher","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Centre for Optimisation of Medicines, School of Health and Clinical Sciences, University of Western Australia, Crawley, WA 6009, Australia"},{"name":"Institute for Paediatric Perioperative Excellence, University of Western Australia, Perth, WA 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"ref_1","unstructured":"PubChem (2025, March 15). PubChem Compound Summary for CID 5447130, Nitrofurazone, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Nitrofurazone."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1021\/acs.jced.3c00112","article-title":"Solubility and Thermodynamic Modeling of 5-Nitrofurazone in Pure Solvents and Binary Solvent Mixtures","volume":"68","author":"Li","year":"2023","journal-title":"J. Chem. Eng. Data"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/chromsci\/48.8.647","article-title":"HPLC-DAD Stability Indicating Determination of Nitrofurazone and Lidocaine Hydrochloride in Their Combined Topical Dosage Form","volume":"48","author":"Shaalan","year":"2010","journal-title":"J. Chromatogr. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0378-5173(92)90177-4","article-title":"A Stability-Indicating Assay for Nitrofurazone by Paper Chromatography","volume":"82","author":"Shahjahan","year":"1992","journal-title":"Int. J. Pharm."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0378-5173(98)00079-9","article-title":"Determination of Nitrofurazone in Some Pharmaceutical Preparations","volume":"168","author":"Shahjahan","year":"1998","journal-title":"Int. J. Pharm."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF01242428","article-title":"Four Spectrophotometric Methods for Determination of Nitrofurazone in Pharmaceutical Formulations","volume":"108","author":"Sastry","year":"1992","journal-title":"Microchim. Acta"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0731-7085(99)00044-8","article-title":"Cathodic Stripping Voltammetric Behaviour of Nitrofurazone and Its Determination in Pharmaceutical Dosage Form, Urine and Serum by Linear Sweep Voltammetry","volume":"20","author":"Khodari","year":"1999","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.aca.2006.08.058","article-title":"Flow Injection Chemiluminescence Determination of Nitrofurazone in Pharmaceutical Preparations and Biological Fluids Based on Oxidation by Singlet Oxygen Generated in N-Bromosuccinimide\u2013Hydrogen Peroxide Reaction","volume":"582","author":"Du","year":"2007","journal-title":"Anal. Chim. Acta"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10895-008-0323-4","article-title":"A Simple and Sensitive Spectrofluorimetric Method for Analysis of Some Nitrofuran Drugs in Pharmaceutical Preparations","volume":"18","author":"Belal","year":"2008","journal-title":"J. Fluoresc."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/jaoac\/85.1.20","article-title":"Liquid Chromatographic Determination of Multiple Sulfonamides, Nitrofurans, and Chloramphenicol Residues in Pasteurized Milk","volume":"85","author":"Perez","year":"2019","journal-title":"J. AOAC Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0021-9673(97)00247-1","article-title":"Determination of Nitrofuran Residues in Avian Eggs by Liquid Chromatography\u2013UV Photodiode Array Detection and Confirmation by Liquid Chromatography\u2013Ionspray Mass Spectrometry","volume":"777","author":"Draisci","year":"1997","journal-title":"J. Chromatogr. A"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/10826070500451962","article-title":"Simultaneous Determination and Identification of Furazolidone, Furaltadone, Nitrofurazone, and Nitrovin in Feeds by HPLC and LC-MS","volume":"29","author":"Wang","year":"2006","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"ref_13","unstructured":"United States Pharmacopeial Convention (2025). Nitrofurazone Ointment. United States Pharmacopeia\u2014National Formulary (USP-NF), United States Pharmacopeial Convention. Monograph."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0021-9673(00)87980-7","article-title":"Highly Specific and Sensitive Detection Method for Nitrofurans by Thin-Layer Chromatography","volume":"208","author":"Veale","year":"1981","journal-title":"J. Chromatogr. A"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/2229-4708.84436","article-title":"High-Performance Thin Layer Chromatography: A Powerful Analytical Technique in Pharmaceutical Drug Discovery","volume":"2","author":"Attimarad","year":"2011","journal-title":"Pharm. Methods"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.7717\/peerj-achem.33","article-title":"Authentication of Jarrah (Eucalyptus marginata) Honey through Its Nectar Signature and Assessment of Its Typical Physicochemical Characteristics","volume":"6","author":"Islam","year":"2024","journal-title":"PeerJ Anal. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Islam, M.K., Pradhan, M., Nguyen, A.V., and Locher, C. (2020). Sugar Profiling of Honeys for Authentication and Detection of Adulterants Using High-Performance Thin Layer Chromatography. Molecules, 25.","DOI":"10.3390\/molecules25225289"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00764-020-00054-9","article-title":"A Validated Method for the Quantitative Determination of Sugars in Honey Using High-Performance Thin-Layer Chromatography","volume":"33","author":"Islam","year":"2020","journal-title":"J. Planar Chromatogr. Mod. TLC"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00764-021-00105-9","article-title":"Development and Validation of a High-Performance Thin-Layer Chromatography Assay for the Analysis of Tacrolimus Ointments","volume":"34","author":"Islam","year":"2021","journal-title":"J. Planar Chromatogr. Mod. TLC"},{"key":"ref_20","first-page":"7","article-title":"Formulation, evaluation and HPTLC fingerprinting of topical ointments containing Cassia tora Linn. leaf extracts","volume":"27","author":"Singh","year":"2014","journal-title":"Int. J. Pharm. Sci. Rev. Res."},{"key":"ref_21","unstructured":"International Council for Harmonisation (ICH) (2022). Validation of Analytical Procedures Q2(R2), ICH."},{"key":"ref_22","unstructured":"Food and Drug Administration (FDA), Center for Veterinary Medicine (2010). Guidance for Industry: Validation of Analytical Procedures for Type C Medicated Feeds, U.S. Department of Health and Human Services, FDA."},{"key":"ref_23","unstructured":"Pharmaceutical Society of Australia (2021). Australian Pharmaceutical Formulary and Handbook: A Guide to Best Practice, Pharmaceutical Society of Australia. [25th ed.]."},{"key":"ref_24","unstructured":"McEvoy, G.K. (1993). American Hospital Formulary Service\u2014Drug Information 93, American Society of Hospital Pharmacists."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-5173(96)04693-5","article-title":"Photolability of Nitrofurazone in Aqueous Solution II. Kinetic Studies","volume":"143","author":"Shahjahan","year":"1996","journal-title":"Int. J. Pharm."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/16\/3429\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:31:41Z","timestamp":1760034701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/16\/3429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":25,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["molecules30163429"],"URL":"https:\/\/doi.org\/10.3390\/molecules30163429","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]}}}